Medicare Enrolled
Dr. Olukemi Wallace, M.D.
Optician · Inglewood, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wallace from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wallace?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wallace
Dr. Olukemi Wallace is an optician specialist in Inglewood, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wallace performed 11,395 Medicare services across 1,398 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wallace received a total of $8,669 from 68 pharmaceutical and/or device companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wallace is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in CA
$8,669 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,395
Medicare services
Top 8% in CA for optician
1,398
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~600 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,052 | $0 | $4 |
| Anti-nausea injection (ondansetron/Zofran) | 1,300 | $0 | $3 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
784 | $126 | $164 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
697 | $104 | $245 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
573 | $76 | $162 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
549 | $12 | $22 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
489 | $27 | $49 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
463 | $8 | $13 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
448 | $51 | $81 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
394 | $42 | $100 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
381 | $1 | $15 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
334 | $30 | $81 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
330 | $26 | $45 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
314 | $8 | $15 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
277 | $124 | $225 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
276 | $105 | $150 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
262 | $1 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
180 | $61 | $104 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
166 | $13 | $33 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
132 | $60 | $118 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
132 | $14 | $32 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
115 | $1 | $2 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
113 | $43 | $70 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
96 | $156 | $316 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
89 | $6 | $18 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
76 | $102 | $150 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
66 | $28 | $52 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
59 | $18 | $30 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
35 | $33 | $325 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
34 | $32 | $62 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
32 | $26 | $64 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $126 | $328 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
30 | $144 | $160 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
26 | $20 | $27 |
| New patient office visit, complex (60-74 min) | 20 | $174 | $392 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
18 | $10 | $25 |
| Tuberculosis skin test A small amount of fluid is injected under the skin to check for a reaction that indicates exposure to tuberculosis bacteria. |
12 | $7 | $10 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
11 | $183 | $207 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.3% high complexity
38.3% medium
45.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,669
Total received (2018-2024)
Avg $1,238/year across 7 years
Top 16% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
351
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,061 (81.5%)
Other
Charitable contributions, space rental, and other categories
$1,198 (13.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$409 (4.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,319
2023
$3,495
2022
$76
2021
$103
2020
$29
2019
$94
2018
$552
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,198
PFIZER INC.
$438
Celgene Corporation
$249
Eisai Inc.
$210
AstraZeneca Pharmaceuticals LP
$201
Incyte Corporation
$180
Alexion Pharmaceuticals, Inc.
$169
Merck Sharp & Dohme LLC
$166
Daiichi Sankyo Inc.
$109
Astellas Pharma US Inc
$103
ARRAY BIOPHARMA INC
$93
Janssen Biotech, Inc.
$89
BeiGene USA, Inc.
$77
GENZYME CORPORATION
$73
Bayer Healthcare Pharmaceuticals Inc.
$71
ABBVIE INC.
$66
Lilly USA, LLC
$62
SUN PHARMACEUTICAL INDUSTRIES INC.
$60
GlaxoSmithKline, LLC.
$59
Gilead Sciences, Inc.
$58
Genentech USA, Inc.
$57
EMD Serono, Inc.
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$45
Regeneron Healthcare Solutions, Inc.
$36
Dendreon Pharmaceuticals LLC
$35
Blueprint Medicines Corporation
$32
Stemline Therapeutics Inc.
$30
Aveo Pharmaceuticals, Inc.
$30
PUMA BIOTECHNOLOGY, INC.
$30
Ipsen Biopharmaceuticals, Inc
$28
SOBI, INC
$26
Kyowa Kirin, Inc.
$25
MorphoSys, US Inc.
$24
TAIHO ONCOLOGY, INC.
$21
Agios Pharmaceuticals, Inc.
$19
Rigel Pharmaceuticals, Inc.
$18
Mirati Therapeutics, Inc.
$17
Chiesi USA, Inc.
$14
Top 3 companies account for 43.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,435
PFIZER INC.
$764
Merck Sharp & Dohme LLC
$457
Celgene Corporation
$413
E.R. Squibb & Sons, L.L.C.
$333
Bayer Healthcare Pharmaceuticals Inc.
$307
AstraZeneca Pharmaceuticals LP
$274
Genentech USA, Inc.
$269
Takeda Pharmaceuticals U.S.A., Inc.
$253
Incyte Corporation
$245
Alexion Pharmaceuticals, Inc.
$243
Gilead Sciences, Inc.
$243
Eisai Inc.
$223
Astellas Pharma US Inc
$188
Janssen Biotech, Inc.
$166
Daiichi Sankyo Inc.
$160
Lilly USA, LLC
$154
Regeneron Healthcare Solutions, Inc.
$126
Puma Biotechnology, Inc.
$117
BeiGene USA, Inc.
$117
GENZYME CORPORATION
$115
Blueprint Medicines Corporation
$95
ARRAY BIOPHARMA INC
$93
Boehringer Ingelheim Pharmaceuticals, Inc.
$93
GlaxoSmithKline, LLC.
$91
EMD Serono, Inc.
$91
AbbVie Inc.
$89
CONMED Corporation
$84
ABBVIE INC.
$66
SOBI, INC
$65
MorphoSys, US Inc.
$64
Dendreon Pharmaceuticals LLC
$64
Exelixis Inc.
$63
SUN PHARMACEUTICAL INDUSTRIES INC.
$60
PharmaEssentia USA Corporation
$59
Seagen Inc.
$52
Amgen Inc.
$49
Otsuka America Pharmaceutical, Inc.
$47
Pharmacyclics LLC, An AbbVie Company
$47
Stemline Therapeutics Inc.
$46
JAZZ PHARMACEUTICALS INC.
$44
Helsinn Therapeutics (U.S.), Inc.
$44
Intuitive Surgical, Inc.
$44
Ipsen Biopharmaceuticals, Inc
$43
Rigel Pharmaceuticals, Inc.
$40
Mirati Therapeutics, Inc.
$38
Karyopharm Therapeutics Inc.
$36
Chiesi USA, Inc.
$31
Aveo Pharmaceuticals, Inc.
$30
PUMA BIOTECHNOLOGY, INC.
$30
AVEO Pharmaceuticals, Inc.
$26
RECORDATI_RARE_DISEASES_INC.
$25
Verity Pharmaceuticals Inc.
$25
Kyowa Kirin, Inc.
$25
Fennec Pharmaceuticals, Inc.
$25
Teva Pharmaceuticals USA, Inc.
$24
Pharmacosmos Therapeutics Inc.
$22
Octapharma USA, Inc.
$21
TAIHO ONCOLOGY, INC.
$21
CTI BioPharma Corp.
$20
Progenics Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme Corporation
$19
Foundation Medicine, Inc.
$19
Agios Pharmaceuticals, Inc.
$19
Shire North American Group Inc
$18
ImmunoGen, Inc.
$17
ACCORD HEALTHCARE, INC.
$13
Emmaus Medical, Inc.
$12
Top 3 companies account for 30.6% of all-time payments
Associated products mentioned in payments ›
AKYNZEO · ALIMTA · ALUNBRIG · ANORO · AYVAKIT · AirSeal · Alecensa · Avastin · BAVENCIO · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CAMCEVI · CARVYKTI · DARZALEX · DOPTELET · DUPIXENT · Da Vinci Surgical System · Doptelet · ELAHERE · ELITEK · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · Elahere · Endari · Enhertu · FERRIPROX · FOTIVDA · FOUNDATIONONE LIQUID CDX · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Neulasta · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Pedmark · Phesgo · Pomalyst · Poteligeo · REBLOZYL · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SPRYCEL · SYLVANT · Stivarga · TAGRISSO · TALVEY · TECENTRIQ · TIVDAK · TUKYSA · Tecentriq · Trelstar · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Vonjo · Vyloy · WAINUA · XALKORI · XPOVIO · XTANDI · Xospata · YONSA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
1,634
Per 100K population
16.6
County median income
$87,760
Nearest hospital
CENTINELA HOSPITAL MEDICAL CENTER
1.6 mi
1.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wallace is a clinical cardiology specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wallace experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Wallace performed 2,052 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wallace receive payments from pharmaceutical companies?
Yes. Dr. Wallace received a total of $8,669 from 68 companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wallace's costs compare to other opticians in Inglewood?
Dr. Wallace's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wallace) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Inglewood
Browse opticians in Inglewood ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology